A 52-year-old female patient with obesity (BMI 35 kg/m2), OSA, and osteoarthritis seeks advice on weight management. Her current medications include paroxetine (an SSRI) for depression and cetirizine (an antihistamine) for allergies. Which of the following is the BEST strategy to help her achieve significant weight loss and improve her comorbid conditions? A. Discontinue paroxetine and cetirizine, and start semaglutide, with close monitoring for changes in mood and allergy symptoms B. Add phentermine/topiramate to her current regimen to promote weight loss and recommend she increase physical activity to alleviate osteoarthritis symptoms C. Initiate semaglutide for weight management, consider adjusting paroxetine therapy to minimize weight gain, and address osteoarthritis with non-pharmacologic interventions D. Focus on lifestyle modifications alone, as pharmacotherapy is unlikely to provide additional benefits for weight loss or her comorbidities E. Unsure
[Answered]: A 52-year-old female patient with obesity (BMI 35…
Need help with your Psychopharmacology case study or NCLEX preparation? Connect with a verified Nursing expert now.